COLLEGE PARK, Md.--(BUSINESS WIRE)-- IonQ (NYSE: IONQ), the leader in the quantum computing and networking industries, today announced it has entered into a definitive agreement to acquire Vector ...
The "Viral Vector Vaccines - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering. The global market for Viral Vector Vaccines was estimated at US$773.4 Million in ...
All-stock deal will broaden IonQ’s quantum technology portfolio, making it the most complete quantum platform available The addition of Vector Atomic’s field-validated portfolio of high-performance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback